ARKEMA/S (OTCMKTS:ARKAY) Rating Lowered to Equal Weight at Barclays
A number of other research firms have also commented on ARKAY. Zacks Investment Research lowered shares of ARKEMA/S from a buy rating to a hold rating in a research note on Wednesday, January 15th. ValuEngine raised shares of ARKEMA/S from a sell rating to a hold rating in a research note on Friday, January 10th.
ARKAY opened at $97.55 on Thursday. ARKEMA/S has a fifty-two week low of $80.75 and a fifty-two week high of $108.19. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.74 and a quick ratio of 1.16. The firm has a market capitalization of $7.48 billion, a price-to-earnings ratio of 12.67 and a beta of 1.39. The company’s 50 day moving average price is $104.09 and its two-hundred day moving average price is $96.87.
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. It operates through three segments: High Performance Materials, Industrial Specialties, and Coating Solutions. Its products include acrylics, coating resins, electroactive polymers, fluorochemicals, fluoropolymers, functional polyolefins, hydrazine hydrate, hydrogen peroxide, molecular sieves, organic peroxide, oxygenated solvents, poly-ether-ketone-ketone polyetherketoneketone, plastic additives, polymethyl methacrylate resins and sheets, rheology additives, solutions for glass coating, specialty adhesives, specialty polyamides, surfactants and additives, technical fluids, and thiochemicals.
Featured Article: What is Cost of Goods Sold (COGS)?
Receive News & Ratings for ARKEMA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARKEMA/S and related companies with MarketBeat.com's FREE daily email newsletter.